HDAC6-IN-16 is a quinazolinone-based HDAC6 inhibitor with anticancer properties. It suppresses cancer cell proliferation by inhibiting colony formation, inducing G2/M cell cycle arrest, and promoting apoptosis in vitro, making it a useful tool for oncology and epigenetics research.
Molecular Weight:
417.48
Formula:
C23H19N3O3S
Target:
HDAC,Apoptosis
* VAT and and shipping costs not included. Errors and price changes excepted
